Clinical Trial Update: The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether increasing dialysate calcium alters T50 in people with secondary hyperparathyroidism and end-stage kidney disease; sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease
• Hyperparathyroidism

Snippet

Sponsor: Iain Bressendorff | Conditions: Secondary Hyperparathyroidism, End-stage Kidney Disease | Phase 2 | Status: NOT_YET_RECRUITING